These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 35703643)
21. Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases. Dupont LL; Glynos C; Bracke KR; Brouckaert P; Brusselle GG Pulm Pharmacol Ther; 2014 Oct; 29(1):1-6. PubMed ID: 25043200 [TBL] [Abstract][Full Text] [Related]
22. In vivo exposure to carbon monoxide causes delayed impairment of activation of soluble guanylate cyclase by nitric oxide in rat brain cortex and cerebellum. Hernández-Viadel M; Castoldi AF; Coccini T; Manzo L; Erceg S; Felipo V J Neurochem; 2004 Jun; 89(5):1157-65. PubMed ID: 15147508 [TBL] [Abstract][Full Text] [Related]
23. Dysfunctional nitric oxide signalling increases risk of myocardial infarction. Erdmann J; Stark K; Esslinger UB; Rumpf PM; Koesling D; de Wit C; Kaiser FJ; Braunholz D; Medack A; Fischer M; Zimmermann ME; Tennstedt S; Graf E; Eck S; Aherrahrou Z; Nahrstaedt J; Willenborg C; Bruse P; Brænne I; Nöthen MM; Hofmann P; Braund PS; Mergia E; Reinhard W; Burgdorf C; Schreiber S; Balmforth AJ; Hall AS; Bertram L; Steinhagen-Thiessen E; Li SC; März W; Reilly M; Kathiresan S; McPherson R; Walter U; ; Ott J; Samani NJ; Strom TM; Meitinger T; Hengstenberg C; Schunkert H Nature; 2013 Dec; 504(7480):432-6. PubMed ID: 24213632 [TBL] [Abstract][Full Text] [Related]
24. The alpha2beta1 isoform of guanylyl cyclase mediates plasma membrane localized nitric oxide signalling. Bellingham M; Evans TJ Cell Signal; 2007 Oct; 19(10):2183-93. PubMed ID: 17643962 [TBL] [Abstract][Full Text] [Related]
25. Soluble guanylate cyclase stimulators as a potential therapy for PAH: enthusiasm, pragmatism and concern. Michelakis ED Eur Respir J; 2009 Apr; 33(4):717-21. PubMed ID: 19336588 [No Abstract] [Full Text] [Related]
27. Nucleotidyl cyclase activity of soluble guanylyl cyclase in intact cells. Bähre H; Danker KY; Stasch JP; Kaever V; Seifert R Biochem Biophys Res Commun; 2014 Jan; 443(4):1195-9. PubMed ID: 24380860 [TBL] [Abstract][Full Text] [Related]
28. Human soluble guanylate cyclase as a nitric oxide sensor for NO-signalling reveals a novel function of nitrite reductase. Pan J; Xu Q; Lin YW; Zhong F; Tan X Chem Commun (Camb); 2013 Aug; 49(67):7454-6. PubMed ID: 23864033 [TBL] [Abstract][Full Text] [Related]
29. Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle. Ijioma SC; Challiss RA; Boyle JP Br J Pharmacol; 1995 Jul; 115(5):723-32. PubMed ID: 8548169 [TBL] [Abstract][Full Text] [Related]
30. NO binds to the distal site of haem in the fully activated soluble guanylate cyclase. Liu R; Kang Y; Chen L Nitric Oxide; 2023 May; 134-135():17-22. PubMed ID: 36972843 [TBL] [Abstract][Full Text] [Related]
31. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis. Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311 [TBL] [Abstract][Full Text] [Related]
32. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia. Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618 [TBL] [Abstract][Full Text] [Related]
36. [Soluble guanylate cyclase in the molecular mechanism underlying the therapeutic action of drugs]. Piatakova NV; Severina IS Biomed Khim; 2012; 58(1):32-42. PubMed ID: 22642150 [TBL] [Abstract][Full Text] [Related]
37. Identification of downstream target genes regulated by the nitric oxide-soluble guanylate cyclase-cyclic guanosine monophosphate signal pathway in pulmonary hypertension. Zou L; Xu X; Zhai Z; Yang T; Jin J; Xiao F; Wang C J Int Med Res; 2016 Jun; 44(3):508-19. PubMed ID: 27048385 [TBL] [Abstract][Full Text] [Related]
38. Soluble Guanylate Cyclase-Mediated Relaxation in Aortas from Rats with Renovascular Hypertension. Tawa M; Shimosato T; Nakagawa K; Okamura T; Ohkita M Pharmacology; 2022; 107(3-4):235-240. PubMed ID: 34929695 [TBL] [Abstract][Full Text] [Related]
39. cGMP becomes a drug target. Schlossmann J; Schinner E Naunyn Schmiedebergs Arch Pharmacol; 2012 Mar; 385(3):243-52. PubMed ID: 22297800 [TBL] [Abstract][Full Text] [Related]
40. Functional coupling of nitric oxide synthase and soluble guanylyl cyclase in controlling catecholamine secretion from bovine chromaffin cells. Schwarz PM; Rodriguez-Pascual F; Koesling D; Torres M; Förstermann U Neuroscience; 1998 Jan; 82(1):255-65. PubMed ID: 9483518 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]